Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113554 · ClinicalTrials.gov registry record · NA
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01113554: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT01113554 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01113554, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
RATIONALE: A breast cancer rehabilitation program and exercise therapy may help improve the quality of life of breast cancer survivors. PURPOSE: This clinical trial studies a breast cancer rehabilitation program in improving quality of life in breast cancer survivors.
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- PROCEDURE quality-of-life assessment
- BEHAVIORAL exercise intervention
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01113554 record still lists
NCT01113554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01113554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01113554 about?
NCT01113554 is a clinical study titled "Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors". RATIONALE: A breast cancer rehabilitation program and exercise therapy may help improve the quality of life of breast cancer survivors. PURPOSE: This clinical trial studies a breast cancer rehabilitation program in improving quality of life in breast cancer survivors.
What is the current status of trial NCT01113554?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2010-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01113554?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), quality-of-life assessment (PROCEDURE), exercise intervention (BEHAVIORAL), management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT01113554?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01113554's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia